chr14-24370177-C-A
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_004554.5(NFATC4):c.779C>A(p.Pro260Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000081 in 1,605,214 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P260L) has been classified as Uncertain significance.
Frequency
Consequence
NM_004554.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
NFATC4 | NM_004554.5 | c.779C>A | p.Pro260Gln | missense_variant | 2/10 | ENST00000250373.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
NFATC4 | ENST00000250373.9 | c.779C>A | p.Pro260Gln | missense_variant | 2/10 | 1 | NM_004554.5 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152240Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000125 AC: 3AN: 239634Hom.: 0 AF XY: 0.00000761 AC XY: 1AN XY: 131376
GnomAD4 exome AF: 0.00000757 AC: 11AN: 1452974Hom.: 0 Cov.: 34 AF XY: 0.00000830 AC XY: 6AN XY: 723236
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152240Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74372
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 17, 2022 | The c.779C>A (p.P260Q) alteration is located in exon 2 (coding exon 2) of the NFATC4 gene. This alteration results from a C to A substitution at nucleotide position 779, causing the proline (P) at amino acid position 260 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at